Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Explore which funds have the lowest turnover to help you improve tax efficiency and overall portfolio resilience. Learn how turnover affects returns and where to look for low-turnover options.
26,816 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Two heavyweights vie for leadership in AI cooling and data-center resilience. This guide breaks down which stock—NVEN...
Casual dining is turning a corner. Chili's posted an eye-catching 8.6% same-store sales gain, signaling a broader shi...
Investors are watching green brick (grbk) earnings closely to gauge the company’s growth trajectory and margin health...
February’s jobs data showed a modest payroll gain, but economists say AI is not the main driver of the softness. The ...
The crypto market has questions about XRP at sub-$1.50 levels. This guide weighs the risks and potential rewards, off...
Deutsche Bank revealed a $30 billion private credit exposure, roughly 2.1% of its asset base, triggering a stock pull...
MP Materials is capturing attention as the only fully integrated u.s. rare earth producer. With buzz around potential...
Semiconductors have sprinted this year, but a cooling period is drawing attention. History suggests pauses can lead t...
Zeta Global is accelerating its AI-powered strategy, unlocking new growth channels and investor potential. This artic...
A major AI data center deal helped IREN stock pop today, signaling potential upside beyond a single headline. This gu...
A harsh public claim about Val Kilmer’s behavior on a past project has reopened debates about how reputation affects ...